Okayama, Japan

Akihiko Taniguchi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Okayama University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akihiko Taniguchi. Retrieved from https://idiyas.com/inventor/akihiko-taniguchi-yq0ajefc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akihiko Taniguchi: Innovator in Medicinal Composition

Introduction

Akihiko Taniguchi is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of medicinal compositions, particularly in the treatment of inflammatory respiratory diseases. His innovative approach has garnered attention in the scientific community.

Latest Patents

Taniguchi holds a patent for a medicinal composition aimed at preventing or treating inflammatory respiratory diseases. The patent describes a method that involves administering an effective amount of an RXR agonist as an active ingredient. This composition is represented by specific formulas, which are defined in detail within the patent documentation. He has 1 patent to his name.

Career Highlights

Taniguchi is affiliated with Okayama University, where he conducts research and development in the field of medicinal chemistry. His work focuses on creating effective treatments for respiratory conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Some of his notable coworkers include Arihiko Kanehiro and Utako Fujii. Their collaborative efforts contribute to the advancement of research in medicinal compositions and related fields.

Conclusion

Akihiko Taniguchi's work in developing medicinal compositions for respiratory diseases highlights his innovative spirit and commitment to healthcare. His contributions are paving the way for new treatment options in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…